How many acquisitions has Alkermes made so far?

Alkermes has completed 3 acquisitions so far, with an average acquisition amount of $744M.

Which countries does Alkermes usually acquire in?

Alkermes has made acquisitions in 3 countries with the most activity in South Korea and United States.

Which is Alkermes' latest acquisition?

Alkermes's most recent acquisition is Avadel Pharmaceuticals, a Pharma company with proprietary drug delivery tools and drug for narcolepsy, acquired in October 2025.

In which year did Alkermes make the most acquisitions?

Alkermes was most active in 2025, with 1 acquisition completed in that year.

List of 3 Acquisitions by Alkermes (Nov 2026)

Most viewed in 2019

Alkermes has made a total of 3 acquisitions. These were completed across South Korea, United States, and Ireland in 5 sectors: Neurology, Nanotechnology, Sleep Medicine, Biotechnology, and Pharmaceuticals. Acquisition activity peaked in 2025, 2019, and 1992, with 1 acquisition recorded in each year. The average number of acquisitions per year between 2020 and 2025 is 0.2, and 0 acquisitions were completed in the current calendar year. The most recent acquisition is Avadel Pharmaceuticals, a company founded in 1990 in Dublin, Ireland, that specializes in proprietary drug delivery tools and a narcolepsy treatment. This acquisition was finalized in October 2025.

Here's the year on year acquisition history of Alkermes:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2019	1
1992	1

View all Acquisitions by Alkermes

Recent acquisitions by Alkermes

Alkermes's most recent acquisition - Avadel Pharmaceuticals is a Pharma company with proprietary drug delivery tools and drug for narcolepsy, founded in 1990 and located in Dublin. Alkermes acquired it in October 2025 for a price of $*****.

Here is the list of all acquisitions by Alkermes sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Oct 22, 2025	Avadel Pharmaceuticals	o{mu	heib	14	445
Nov 18, 2019	Rodin Therapeutics	sjnk	xstc	35	218
Dec 07, 1992	Enzytech	jwnr	byzu	12	987

Media has covered Alkermes for a total of 33 events in the last 1 year, 6 of them have been about acquisition activity.

•

Alkermes set to report earnings after Avadel acquisition closeInvesting•Feb 24, 2026•Avadel Pharmaceuticals, Alkermes

•

Avadel Pharma Announces Court Sanction of Alkermes AcquisitionGlobeNewswire•Feb 11, 2026•Avadel Pharmaceuticals, Alkermes, Allianz

•

Alkermes plans Avadel acquisition to expand sleep portfolioTipRanks•Jan 12, 2026•Alkermes, Avadel Pharmaceuticals

•

Avadel Accepts Alkermes’ Revised $2.37B Counteroffer, Besting LundbeckBioSpace•Nov 19, 2025•Avadel Pharmaceuticals, Alkermes, Lundbeck

•

Alkermes Considers Responding to Lundbeck's Acquisition Offer for AbadelInvesting•Nov 14, 2025•Avadel Pharmaceuticals, Alkermes, Lundbeck

•

Alkermes to Acquire Avadel Pharmaceuticals in $2.1 Billion DealGlobal Legal Chronicle•Nov 13, 2025•Avadel Pharmaceuticals, Alkermes, Dennys, Monteverde and 2 others

View More Alkermes Recent News

View all Acquisitions by Alkermes

Acquisitions by Alkermes

List of Alkermes's Acquisitions

Recent acquisitions by Alkermes

News related to Alkermes's acquisitions

FAQs about Acquisitions by Alkermes